NanoLogix, Inc. (OTCPK: NNLX)
Health Care · Biotechnology · US
$—
— today · — 1Y
NanoLogix, Inc. (OTCPK: NNLX) operates in the Biotechnology industry within the Health Care sector. The company is valued at $13.03K and employs 7 people.
trading between 0.00 and 0.04.
Tweenvest scores NanoLogix, Inc. across four factors: quality 26/100, value 51/100. Its strongest factor is value.
NNLX price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $13.03K
- Revenue (TTM)
- $1.27K
- P/E
- —
- EPS
- -0.02
- Dividend yield
- —
- Beta (5Y)
- -92.46
- 52-week high
- $0.04
- 52-week low
- $0.00
- Avg volume (3M)
- —
- Shares outstanding
- 162.89M
- Employees
- 7
- Next earnings
- —
About NanoLogix, Inc.
NanoLogix, Inc., a biotechnology firm, specializes in developing and providing rapid diagnostic and live cell test kits. These kits are designed to accurately detect viable bacteria and a wide array of other microorganisms. Among its key offerings are the BioNanoPore kit, which utilizes a unique water-permeable membrane capable of interacting with organic, inorganic molecules, and proteins. Another significant product is the FlatPack Petri Plate, essential for the isolation and cultivation of diverse microorganisms, including both fastidious and non-fastidious types, as well as those requiring or not requiring oxygen for growth (aerobic and anaerobic respectively). The company's solutions are applied across a broad spectrum of sectors, including medical diagnostics, national defense, homeland security initiatives, pharmaceutical research and manufacturing, industrial processes, veterinary science, and environmental monitoring. NanoLogix serves an established clientele comprising prominent medical and scientific organizations. This includes laboratories, healthcare institutions, academic universities, various businesses, and specialized research establishments. Headquartered in Hubbard, Ohio, NanoLogix, Inc. operates from this location.
- ISIN
- US6300761078
- Listed since
- Sep 8, 2009
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $468.22B | $263.45 | -0.57% |
| Amgen Inc.NasdaqGS: AMGN | $237.52B | $440.67 | +0.31% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $181.18B | $145.57 | -0.38% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $138.91B | $547.80 | -0.05% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $83.28B | $824.34 | -1.16% |
| argenx SEENXTBR: ARGX | $65.85B | €867.40 | -3.84% |
| Moderna, Inc.NasdaqGS: MRNA | $57.92B | $137.35 | -5.33% |
| CSL LimitedASX: CSL | $57.77B | AU$168.30 | -1.69% |
Figures last refreshed Aug 18, 2026.